
NASDAQConsumer DefensiveHousehold & Personal Products
最新データ
$6.88
−$0.1221 · -1.74%
United-Guardian, Inc., operating both domestically and globally, specializes in the development, production, and distribution of a diverse range of cosmetic raw materials, pharmaceutical solutions, medical-grade lubricants, and proprietary industrial chemicals. Its extensive cosmetic ingredients catalog includes the LUBRAJEL line of water-based moisturizing and lubricating gel formulations, featuring variants such as LUBRAJEL NATURAL (derived from natural sources), LUBRAJEL MARINE, and LUBRASIL II SB (a silicone-infused LUBRAJEL formulation). Other key offerings in this category are LUBRAJEL II XD; B-122, a powdered lubricant suitable for pressed powders, eyeliners, blushes, and industrial uses; KLENSOFT, a surfactant for shampoos, shower gels, and makeup removers; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, and cleansers. For medical applications, United-Guardian provides lubricants like LUBRAJEL RR and RC, which are water-based gels specifically designed for urinary catheters. LUBRAJEL MG serves to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices. The company also offers LUBRAJEL LC and LUBRAJEL FA, specialized LUBRAJEL formulations tailored for oral care, alongside LUBRAJEL FLUID for lubricating various water-soluble products. The pharmaceutical portfolio features RENACIDIN, a prescription medication for preventing and dissolving calcifications in urethral catheters and the urinary bladder. Also included is CLORPACTIN WCS-90, an antimicrobial agent effective against infections in the urinary bladder, localized peritoneal infections, and infections affecting the eyes, ears, nose, throat, and sinuses. Industrial products comprise DESELEX, a sequestering and chelating agent vital for detergent manufacturing, and THOROCLENS, a powerful chlorine-based industrial cleaning solution. The firm also dedicates resources to research and development, primarily focusing on advancing cosmetic ingredients. Products are brought to market through a robust network of marketing partners, distributors, and wholesalers. Established in 1942, United-Guardian maintains its headquarters in Hauppauge, New York.
通常取引
$6.88
−$0.1221 · -1.74%
日中の時刻はETです。市場データは遅延する場合があります。
United-Guardian, Inc., operating both domestically and globally, specializes in the development, production, and distribution of a diverse range of cosmetic raw materials, pharmaceutical solutions, medical-grade lubricants, and proprietary industrial chemicals. Its extensive cosmetic ingredients catalog includes the LUBRAJEL line of water-based moisturizing and lubricating gel formulations, featuring variants such as LUBRAJEL NATURAL (derived from natural sources), LUBRAJEL MARINE, and LUBRASIL II SB (a silicone-infused LUBRAJEL formulation). Other key offerings in this category are LUBRAJEL II XD; B-122, a powdered lubricant suitable for pressed powders, eyeliners, blushes, and industrial uses; KLENSOFT, a surfactant for shampoos, shower gels, and makeup removers; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, and cleansers. For medical applications, United-Guardian provides lubricants like LUBRAJEL RR and RC, which are water-based gels specifically designed for urinary catheters. LUBRAJEL MG serves to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices. The company also offers LUBRAJEL LC and LUBRAJEL FA, specialized LUBRAJEL formulations tailored for oral care, alongside LUBRAJEL FLUID for lubricating various water-soluble products. The pharmaceutical portfolio features RENACIDIN, a prescription medication for preventing and dissolving calcifications in urethral catheters and the urinary bladder. Also included is CLORPACTIN WCS-90, an antimicrobial agent effective against infections in the urinary bladder, localized peritoneal infections, and infections affecting the eyes, ears, nose, throat, and sinuses. Industrial products comprise DESELEX, a sequestering and chelating agent vital for detergent manufacturing, and THOROCLENS, a powerful chlorine-based industrial cleaning solution. The firm also dedicates resources to research and development, primarily focusing on advancing cosmetic ingredients. Products are brought to market through a robust network of marketing partners, distributors, and wholesalers. Established in 1942, United-Guardian maintains its headquarters in Hauppauge, New York.
日中レンジ
現在 $6.88
52週レンジ
現在 $6.88
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
中立
バリュエーション
77
割安
センチメント
60
まちまち
リスク
40
中程度のリスク
モメンタム
44
中立
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
United-Guardian, Inc., operating both domestically and globally, specializes in the development, production, and distribution of a diverse range of cosmetic raw materials, pharmaceutical solutions, medical-grade lubricants, and proprietary industrial chemicals. Its extensive cosmetic ingredients catalog includes the LUBRAJEL line of water-based moisturizing and lubricating gel formulations, featuring variants such as LUBRAJEL NATURAL (derived from natural sources), LUBRAJEL MARINE, and LUBRASIL II SB (a silicone-infused LUBRAJEL formulation). Other key offerings in this category are LUBRAJEL II XD; B-122, a powdered lubricant suitable for pressed powders, eyeliners, blushes, and industrial uses; KLENSOFT, a surfactant for shampoos, shower gels, and makeup removers; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, and cleansers. For medical applications, United-Guardian provides lubricants like LUBRAJEL RR and RC, which are water-based gels specifically designed for urinary catheters. LUBRAJEL MG serves to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices. The company also offers LUBRAJEL LC and LUBRAJEL FA, specialized LUBRAJEL formulations tailored for oral care, alongside LUBRAJEL FLUID for lubricating various water-soluble products. The pharmaceutical portfolio features RENACIDIN, a prescription medication for preventing and dissolving calcifications in urethral catheters and the urinary bladder. Also included is CLORPACTIN WCS-90, an antimicrobial agent effective against infections in the urinary bladder, localized peritoneal infections, and infections affecting the eyes, ears, nose, throat, and sinuses. Industrial products comprise DESELEX, a sequestering and chelating agent vital for detergent manufacturing, and THOROCLENS, a powerful chlorine-based industrial cleaning solution. The firm also dedicates resources to research and development, primarily focusing on advancing cosmetic ingredients. Products are brought to market through a robust network of marketing partners, distributors, and wholesalers. Established in 1942, United-Guardian maintains its headquarters in Hauppauge, New York.
日中レンジ
現在 $6.88
52週レンジ
現在 $6.88
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標(USD) | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 1054.55万 USD | 1218.2万 USD | 1088.52万 USD | 1269.85万 USD | 1392.96万 USD |
| 売上原価 | 551.25万 USD | 572.16万 USD | 547.96万 USD | 599.64万 USD | 574.79万 USD |
| 粗利益 | 503.29万 USD | 646.04万 USD | 540.56万 USD | 670.21万 USD | 818.17万 USD |
| 研究開発 | 46.36万 USD | 45.68万 USD | 46.4万 USD | 49.08万 USD | 47.86万 USD |
| 営業費用 | 278.96万 USD | 281.36万 USD | 254.26万 USD | 266.49万 USD | 251.46万 USD |
| 受取利息 | 36.53万 USD | 43.47万 USD | 30.67万 USD | 23.67万 USD | 23.39万 USD |
| 支払利息 | — | — | — | 161.91万 USD | — |
| 減価償却費と償却費 | 10.82万 USD | 9.59万 USD | 10.57万 USD | 13.54万 USD | 14.6万 USD |
| 営業利益 | 224.33万 USD | 364.68万 USD | 286.3万 USD | 403.72万 USD | 566.71万 USD |
| 純利益 | 210.57万 USD | 325.09万 USD | 258.14万 USD | 256.95万 USD | 465.85万 USD |
会社概要が更新されました 2026年10月12日.
直近の発表実績
直近の発表実績
分割調整後の1株当たりの年間現金分配金。
$0.60
2025年(通年)-23.1% 以来 2020
2026年(一部):$0.55
$0.78
2,020
$1.13
2,021
$0.68
2,022
$0.60
2,024
$0.60
2,025
$0.55
2,026*
* 利用可能な配当履歴のうち、暦年の一部のみを含みます。
| 種別 | 配当落ち日 | 詳細 | 基準日 | 支払日 |
|---|---|---|---|---|
配当 | 2026年7月28日 | $0.30Semi-Annual | 2026年7月28日 | 2026年8月4日 |
配当 | 2026年2月9日 | $0.25Semi-Annual | 2026年2月9日 | 2026年2月17日 |
配当 | 2025年7月25日 | $0.25Semi-Annual | 2025年7月25日 | 2025年8月1日 |
配当 | 2025年2月10日 | $0.35Semi-Annual | 2025年2月10日 | 2025年2月18日 |
配当 | 2024年7月23日 | $0.35Semi-Annual | 2024年7月23日 | 2024年7月31日 |
配当 | 2024年2月9日 | $0.25Semi-Annual | 2024年2月12日 | 2024年2月20日 |
配当落ち 2026年7月28日
$0.30
Semi-Annual
2026年7月28日基準 · 支払日 2026年8月4日
配当落ち 2026年2月9日
$0.25
Semi-Annual
2026年2月9日基準 · 支払日 2026年2月17日
配当落ち 2025年7月25日
$0.25
Semi-Annual
2025年7月25日基準 · 支払日 2025年8月1日
配当落ち 2025年2月10日
$0.35
Semi-Annual
2025年2月10日基準 · 支払日 2025年2月18日
配当落ち 2024年7月23日
$0.35
Semi-Annual
2024年7月23日基準 · 支払日 2024年7月31日
配当落ち 2024年2月9日
$0.25
Semi-Annual
2024年2月12日基準 · 支払日 2024年2月20日
この株式へのエクスポージャーを報告している上場投資信託です。
Vanguard Morningstar Total Stock Market ETFVTI65.35万0.00%2.3兆 USD0.03%$381.46-0.13%
Vanguard Extended Market ETFVXF26.07万0.00%954億 USD0.05%$233.86-0.49%
U.S. Micro Cap Portfolio ETFDFMC22.79万0.00%75.58億 USD0.43%$57.80-0.02%
Dimensional - US Small Cap ETFDFAS13.26万0.00%338.69億 USD0.31%$78.365+0.02%
iShares Micro-Cap ETFIWC7.51万0.01%13.17億 USD0.60%$182.02-0.54%
EA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSM5万0.05%1.17億 USD0.73%$15.8401-0.63%
Dimensional - US Core Equity 2 ETFDFAC3.45万0.00%885.96億 USD0.21%$45.335+0.01%
U.S. Core Equity 1 Portfolio ETF Class SharesDCOR1.95万0.00%455.91億 USD0.17%$84.375-0.08%
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Extended Market ETFVXF
U.S. Micro Cap Portfolio ETFDFMC
Dimensional - US Small Cap ETFDFAS
iShares Micro-Cap ETFIWC
EA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSM
Dimensional - US Core Equity 2 ETFDFAC
U.S. Core Equity 1 Portfolio ETF Class SharesDCORAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。